Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of paromomycin and cotrimoxazole for Blastocystis hominis-associated gastrointestinal symptoms
2014-004414-28Phase 4Active
- Sponsor
- MútuaTerrassa
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of paromomycin in Blastocystis hominis infection (3 arms), sponsored by MútuaTerrassa. Primary endpoint: Eradication of Blastocystis hominis. Started Mar 2015; status: active.
02
Drugs
paromomycin
03
Conditions
Blastocystis hominis infection
Beyond the preview
Go deeper on 2014-004414-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004414-28.